Study Evaluating LXR-623 in Healthy Japanese Adults

Phase 1

Completed

• Conditions: Healthy

• Registration Number: NCT00385489
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

The purpose of this study is to evaluate the safety of LXR-623 in healthy Japanese subjects.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-08
• Primary Completion: 2006-09
• Study Completion: 2006-09
• Study First Submitted: 2006-10-05
• Study First Submitted QC: 2006-10-06
• Study First Posted: 2006-10-09
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-06
• Last Update Posted: 2009-08-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• Healthy, Japanese Males aged 20-45 years

Exclusion Criteria

• A history or active presence of clinically important medical disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Safety